| NCT03345485 |
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03345485 |
Active, not recruiting |
Mundipharma-EDO GmbH |
2021-12-31 |
| NCT04334941 |
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker |
https://ClinicalTrials.gov/show/NCT04334941 |
Recruiting |
National Cancer Institute (NCI) |
2025-11-30 |
| NCT02394548 |
Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer |
https://ClinicalTrials.gov/show/NCT02394548 |
Active, not recruiting |
Massachusetts General Hospital |
2019-02-28 |
| NCT04032704 |
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04032704 |
Recruiting |
Seattle Genetics, Inc. |
2021-07-31 |
| NCT03923270 |
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03923270 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2024-05-01 |
| NCT03811002 |
Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03811002 |
Recruiting |
National Cancer Institute (NCI) |
2026-12-28 |
| NCT03649841 |
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03649841 |
Recruiting |
University of Washington |
2022-09-16 |
| NCT03410368 |
NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. |
https://ClinicalTrials.gov/show/NCT03410368 |
Recruiting |
First Hospital of Jilin University |
2019-06-01 |
| NCT03406715 |
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT03406715 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-04-30 |
| NCT03391362 |
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-6 Brain Metastases |
https://ClinicalTrials.gov/show/NCT03391362 |
Recruiting |
Dana-Farber Cancer Institute |
2021-06-30 |
| NCT03382561 |
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03382561 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-06-02 |
| NCT03371979 |
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03371979 |
Active, not recruiting |
Aeglea Biotherapeutics |
2020-12-31 |
| NCT03365791 |
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT03365791 |
Active, not recruiting |
Novartis |
2019-02-21 |
| NCT03823118 |
S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03823118 |
Recruiting |
Taizhou Hospital |
2020-02-28 |
| NCT03333616 |
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors |
https://ClinicalTrials.gov/show/NCT03333616 |
Recruiting |
Dana-Farber Cancer Institute |
2021-05-31 |
| NCT03325816 |
Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03325816 |
Active, not recruiting |
Georgetown University |
2019-03-28 |
| NCT03319940 |
Study Evaluating Safety, Tolerability and PK of AMG 757 in Adults With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03319940 |
Recruiting |
Amgen |
2022-08-07 |
| NCT03305341 |
Discovery Stage IND EXEMPT NDA Clinical Research - Etoposide OS and Single Nucleotide Polymorphisms |
https://ClinicalTrials.gov/show/NCT03305341 |
Active, not recruiting |
Medicine Invention Design, Inc |
2020-04-08 |
| NCT03297424 |
A Study of PLX2853 in Advanced Malignancies. |
https://ClinicalTrials.gov/show/NCT03297424 |
Recruiting |
Plexxikon |
2020-12-31 |
| NCT03262454 |
Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC |
https://ClinicalTrials.gov/show/NCT03262454 |
Recruiting |
National Cancer Center, Korea |
2019-12-31 |
| NCT03239171 |
Bioinformation Therapy for Lung Cancer |
https://ClinicalTrials.gov/show/NCT03239171 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-09-02 |
| NCT03228667 |
QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT03228667 |
Recruiting |
Altor BioScience |
2021-06-30 |
| NCT03227016 |
Study in Patients With SCLC of Veliparib in Combination With Topotecan |
https://ClinicalTrials.gov/show/NCT03227016 |
Recruiting |
Central European Society for Anticancer Drug Research |
2020-12-31 |
| NCT03223155 |
Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer |
https://ClinicalTrials.gov/show/NCT03223155 |
Recruiting |
University of Chicago |
2020-12-31 |
| NCT03221400 |
PEN-866 in Patients With Advanced Solid Malignancies |
https://ClinicalTrials.gov/show/NCT03221400 |
Recruiting |
Tarveda Therapeutics |
2021-12-31 |
| NCT03214003 |
Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC |
https://ClinicalTrials.gov/show/NCT03214003 |
Enrolling by invitation |
Beijing Cancer Hospital |
2020-05-31 |
| NCT03154190 |
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03154190 |
Recruiting |
Stanford University |
2020-11-30 |
| NCT03098030 |
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03098030 |
Completed |
United Therapeutics |
2020-01-27 |
| NCT03092934 |
A Study of AK-01 (LY3295668) in Solid Tumors |
https://ClinicalTrials.gov/show/NCT03092934 |
Active, not recruiting |
Eli Lilly and Company |
2019-12-01 |
| NCT03088813 |
Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03088813 |
Recruiting |
Ipsen |
2022-09-30 |
| NCT03086239 |
A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03086239 |
Completed |
AbbVie |
2018-01-30 |
| NCT03085849 |
SGI-110 Plus Durvalumab/Tremelimumab in SCLC |
https://ClinicalTrials.gov/show/NCT03085849 |
Completed |
Columbia University |
2018-11-26 |
| NCT03083691 |
BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer |
https://ClinicalTrials.gov/show/NCT03083691 |
Enrolling by invitation |
Lung Cancer Group Cologne |
2020-03-31 |
| NCT03080311 |
A Study of APG-1252 in Patients With SCLC or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT03080311 |
Active, not recruiting |
Ascentage Pharma Group Inc. |
2020-06-12 |
| NCT03077854 |
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial |
https://ClinicalTrials.gov/show/NCT03077854 |
Recruiting |
National Taiwan University Hospital |
2021-05-31 |
| NCT03066778 |
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) |
https://ClinicalTrials.gov/show/NCT03066778 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2019-12-18 |
| NCT03061812 |
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) |
https://ClinicalTrials.gov/show/NCT03061812 |
Completed |
AbbVie |
2020-02-12 |
| NCT03059797 |
Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) |
https://ClinicalTrials.gov/show/NCT03059797 |
Completed |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2018-06-30 |
| NCT03059667 |
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03059667 |
Active, not recruiting |
Intergroupe Francophone de Cancerologie Thoracique |
2018-09-10 |
| NCT03043872 |
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) |
https://ClinicalTrials.gov/show/NCT03043872 |
Active, not recruiting |
AstraZeneca |
2020-01-27 |
| NCT03043599 |
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03043599 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2018-10-26 |
| NCT03041311 |
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Extensive Stage Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT03041311 |
Active, not recruiting |
G1 Therapeutics, Inc. |
2018-07-28 |
| NCT03009682 |
Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations |
https://ClinicalTrials.gov/show/NCT03009682 |
Recruiting |
Samsung Medical Center |
2021-09-30 |
| NCT02995902 |
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02995902 |
Completed |
Rigshospitalet, Denmark |
2017-02-08 |
| NCT02995889 |
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer |
https://ClinicalTrials.gov/show/NCT02995889 |
Active, not recruiting |
Rigshospitalet, Denmark |
2019-02-07 |
| NCT02978404 |
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases |
https://ClinicalTrials.gov/show/NCT02978404 |
Active, not recruiting |
Centre hospitalier de l’Université de Montréal (CHUM) |
2021-06-30 |
| NCT02963090 |
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02963090 |
Active, not recruiting |
Alliance Foundation Trials, LLC. |
2019-05-20 |
| NCT02949895 |
Study of BMS-986012 in Subjects With Small Cell Lung Caner |
https://ClinicalTrials.gov/show/NCT02949895 |
Completed |
Bristol-Myers Squibb |
2017-08-29 |
| NCT02937818 |
A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02937818 |
Active, not recruiting |
AstraZeneca |
2020-06-18 |
| NCT02936323 |
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers |
https://ClinicalTrials.gov/show/NCT02936323 |
Active, not recruiting |
Tarveda Therapeutics |
2020-07-31 |
| NCT02934503 |
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT02934503 |
Recruiting |
NYU Langone Health |
2019-10-31 |
| NCT02913443 |
A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC) |
https://ClinicalTrials.gov/show/NCT02913443 |
Completed |
Hoffmann-La Roche |
2017-10-24 |
| NCT02906384 |
Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) |
https://ClinicalTrials.gov/show/NCT02906384 |
Recruiting |
Zhejiang Cancer Hospital |
2018-10-31 |
| NCT02893917 |
Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT02893917 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02881125 |
Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT02881125 |
Completed |
University of Washington |
2018-01-01 |
| NCT02874664 |
A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02874664 |
Completed |
Stemcentrx |
2018-09-12 |
| NCT02815592 |
Trial of BMS-986012 in Combination With Platinum and Etoposide |
https://ClinicalTrials.gov/show/NCT02815592 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-11-30 |
| NCT02769832 |
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer |
https://ClinicalTrials.gov/show/NCT02769832 |
Recruiting |
University of Iowa |
2023-04-30 |
| NCT02735980 |
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02735980 |
Completed |
Eli Lilly and Company |
2017-07-31 |
| NCT02722369 |
STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT02722369 |
Recruiting |
University College, London |
2021-07-31 |
| NCT02721732 |
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic |
https://ClinicalTrials.gov/show/NCT02721732 |
Recruiting |
M.D. Anderson Cancer Center |
2020-08-20 |
| NCT02701400 |
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02701400 |
Active, not recruiting |
Emory University |
2020-10-31 |
| NCT02675088 |
Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02675088 |
Recruiting |
Chinese Academy of Medical Sciences |
2019-12-31 |
| NCT02658214 |
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02658214 |
Completed |
AstraZeneca |
2019-11-14 |
| NCT02649673 |
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies |
https://ClinicalTrials.gov/show/NCT02649673 |
Active, not recruiting |
SCRI Development Innovations, LLC |
2020-07-27 |
| NCT02605811 |
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02605811 |
Recruiting |
Guangzhou Medical University |
2019-12-31 |
| NCT02589522 |
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT02589522 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-30 |
| NCT02580994 |
Pembrolizumab in Untreated Extensive SCLC |
https://ClinicalTrials.gov/show/NCT02580994 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2020-08-31 |
| NCT02573506 |
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02573506 |
Completed |
Sun Yat-sen University |
2020-03-31 |
| NCT04422210 |
A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). |
https://ClinicalTrials.gov/show/NCT04422210 |
Recruiting |
Hoffmann-La Roche |
2024-07-06 |
| NCT02769962 |
Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02769962 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-07-01 |
| NCT02763579 |
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT02763579 |
Active, not recruiting |
Hoffmann-La Roche |
2018-04-24 |
| NCT02674568 |
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02674568 |
Completed |
AbbVie |
2018-10-19 |
| NCT02041845 |
Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02041845 |
Active, not recruiting |
Norwegian University of Science and Technology |
2020-06-30 |
| NCT01450761 |
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone |
https://ClinicalTrials.gov/show/NCT01450761 |
Completed |
Bristol-Myers Squibb |
2015-03-19 |
| NCT02566993 |
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02566993 |
Completed |
PharmaMar |
2020-02-29 |
| NCT03392064 |
A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC |
https://ClinicalTrials.gov/show/NCT03392064 |
Active, not recruiting |
Amgen |
2025-01-13 |
| NCT02551432 |
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02551432 |
Completed |
Seoul National University Hospital |
2017-12-31 |
| NCT02538666 |
An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy |
https://ClinicalTrials.gov/show/NCT02538666 |
Active, not recruiting |
Bristol-Myers Squibb |
2018-10-01 |
| NCT02514447 |
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy |
https://ClinicalTrials.gov/show/NCT02514447 |
Active, not recruiting |
G1 Therapeutics, Inc. |
2018-09-28 |
| NCT03387332 |
APG-1252 in Patients With SCLC or Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03387332 |
Recruiting |
Ascentage Pharma Group Inc. |
2019-12-28 |
| NCT02511795 |
AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02511795 |
Completed |
AstraZeneca |
2019-04-25 |
| NCT02499770 |
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT02499770 |
Completed |
G1 Therapeutics, Inc. |
2017-07-03 |
| NCT02498613 |
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02498613 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02496208 |
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors |
https://ClinicalTrials.gov/show/NCT02496208 |
Recruiting |
National Cancer Institute (NCI) |
2020-09-30 |
| NCT02489903 |
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) |
https://ClinicalTrials.gov/show/NCT02489903 |
Active, not recruiting |
EpicentRx, Inc. |
2020-12-31 |
| NCT02446704 |
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy |
https://ClinicalTrials.gov/show/NCT02446704 |
Recruiting |
Massachusetts General Hospital |
2020-08-31 |
| NCT02402920 |
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02402920 |
Recruiting |
M.D. Anderson Cancer Center |
2023-07-31 |
| NCT02397733 |
Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL) |
https://ClinicalTrials.gov/show/NCT02397733 |
Completed |
Grupo de Investigación ClÃnica en OncologÃa Radioterapia |
2019-12-31 |
| NCT02391480 |
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer |
https://ClinicalTrials.gov/show/NCT02391480 |
Completed |
AbbVie |
2019-07-05 |
| NCT02352948 |
A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02352948 |
Active, not recruiting |
AstraZeneca |
2018-02-09 |
| NCT02349412 |
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers |
https://ClinicalTrials.gov/show/NCT02349412 |
Completed |
Alliance for Clinical Trials in Oncology |
2017-07-03 |
| NCT02337712 |
Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02337712 |
Recruiting |
Sun Yat-sen University |
2020-12-31 |
| NCT02323737 |
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02323737 |
Completed |
Chinese Academy of Medical Sciences |
2011-06-30 |
| NCT02312622 |
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer |
https://ClinicalTrials.gov/show/NCT02312622 |
Completed |
Stanford University |
2018-09-08 |
| NCT02289690 |
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02289690 |
Completed |
AbbVie |
2019-04-17 |
| NCT02247349 |
BMS-986012 in Relapsed/Refractory SCLC |
https://ClinicalTrials.gov/show/NCT02247349 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-09-28 |
| NCT02223052 |
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02223052 |
Completed |
Celgene |
2018-06-11 |
| NCT02200081 |
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC |
https://ClinicalTrials.gov/show/NCT02200081 |
Completed |
Mologen AG |
2016-11-30 |
| NCT02194049 |
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02194049 |
Completed |
University of California, Davis |
2016-04-30 |
| NCT02171325 |
Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment |
https://ClinicalTrials.gov/show/NCT02171325 |
Recruiting |
Guangdong Association of Clinical Trials |
2020-06-30 |
| NCT02164461 |
ADXS11-001 High Dose HPV+ Cervical Cancer |
https://ClinicalTrials.gov/show/NCT02164461 |
Completed |
Advaxis, Inc. |
2017-04-30 |
| NCT02069158 |
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor |
https://ClinicalTrials.gov/show/NCT02069158 |
Completed |
Oncology Institute of Southern Switzerland |
2019-05-31 |
| NCT02058056 |
Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC |
https://ClinicalTrials.gov/show/NCT02058056 |
Completed |
Swiss Group for Clinical Cancer Research |
2018-06-07 |
| NCT01306045 |
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies |
https://ClinicalTrials.gov/show/NCT01306045 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT02046733 |
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease |
https://ClinicalTrials.gov/show/NCT02046733 |
Active, not recruiting |
European Thoracic Oncology Platform |
2020-12-31 |
| NCT02038647 |
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT02038647 |
Completed |
Takeda |
2016-01-03 |
| NCT01999881 |
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients |
https://ClinicalTrials.gov/show/NCT01999881 |
Completed |
University of Wisconsin, Madison |
2015-07-31 |
| NCT01987232 |
Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01987232 |
Completed |
Amgen |
2016-08-31 |
| NCT01935336 |
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers |
https://ClinicalTrials.gov/show/NCT01935336 |
Active, not recruiting |
University of Colorado, Denver |
2017-01-31 |
| NCT01931787 |
CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01931787 |
Completed |
Wake Forest University Health Sciences |
2015-12-31 |
| NCT01901653 |
Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01901653 |
Completed |
Stemcentrx |
2016-11-28 |
| NCT01881906 |
Exercise in Advanced Stage Lung Cancer Patients |
https://ClinicalTrials.gov/show/NCT01881906 |
Completed |
Rigshospitalet, Denmark |
2017-04-12 |
| NCT01880528 |
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer |
https://ClinicalTrials.gov/show/NCT01880528 |
Completed |
Mayo Clinic |
2013-06-05 |
| NCT01876446 |
Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01876446 |
Completed |
Roswell Park Cancer Institute |
2017-07-18 |
| NCT01840579 |
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) |
https://ClinicalTrials.gov/show/NCT01840579 |
Completed |
Merck Sharp & Dohme Corp. |
2020-02-25 |
| NCT01831089 |
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01831089 |
Completed |
PharmaMar |
2016-07-31 |
| NCT01797874 |
Pazopanib Maintenance for SCLC |
https://ClinicalTrials.gov/show/NCT01797874 |
Completed |
Samsung Medical Center |
2017-02-28 |
| NCT01797159 |
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01797159 |
Active, not recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-04-30 |
| NCT01780675 |
Hippocampus Avoidance PCI vs PCI |
https://ClinicalTrials.gov/show/NCT01780675 |
Active, not recruiting |
The Netherlands Cancer Institute |
2019-04-01 |
| NCT01737502 |
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01737502 |
Recruiting |
Mayo Clinic |
2020-08-21 |
| NCT01713296 |
Pazopanib in Relapsed and Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01713296 |
Completed |
Hellenic Oncology Research Group |
2015-03-31 |
| NCT01642251 |
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01642251 |
Completed |
National Cancer Institute (NCI) |
2016-12-08 |
| NCT01638546 |
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01638546 |
Completed |
National Cancer Institute (NCI) |
2017-01-31 |
| NCT01631552 |
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers |
https://ClinicalTrials.gov/show/NCT01631552 |
Active, not recruiting |
Immunomedics, Inc. |
2020-06-30 |
| NCT01579929 |
Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) |
https://ClinicalTrials.gov/show/NCT01579929 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-08-11 |
| NCT01553916 |
Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain |
https://ClinicalTrials.gov/show/NCT01553916 |
Completed |
Washington University School of Medicine |
2016-09-12 |
| NCT01533181 |
Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01533181 |
Completed |
National Cancer Institute (NCI) |
2014-11-30 |
| NCT01505868 |
Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01505868 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2029-07-11 |
| NCT01500720 |
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01500720 |
Completed |
Sanofi |
2014-04-30 |
| NCT01497873 |
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01497873 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-12-31 |
| NCT03348670 |
Discovery Stage IND EXEMPT Clinical Study - Etoposide OS Plus Methotrexate OS and Single Nucleotide Polymorphisms |
https://ClinicalTrials.gov/show/NCT03348670 |
Active, not recruiting |
Medicine Invention Design, Inc |
2020-04-08 |
| NCT01470248 |
Study of Arsenic Trioxide in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01470248 |
Completed |
Emory University |
2016-01-31 |
| NCT01457469 |
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer |
https://ClinicalTrials.gov/show/NCT01457469 |
Completed |
Wake Forest University Health Sciences |
2012-01-31 |
| NCT01441349 |
Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01441349 |
Recruiting |
National Cancer Center, Korea |
2019-12-31 |
| NCT01441297 |
BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01441297 |
Completed |
National Cancer Center, Korea |
2015-10-31 |
| NCT01439568 |
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma |
https://ClinicalTrials.gov/show/NCT01439568 |
Completed |
Eli Lilly and Company |
2014-01-31 |
| NCT01401907 |
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01401907 |
Active, not recruiting |
Massachusetts General Hospital |
2016-04-30 |
| NCT01357395 |
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01357395 |
Completed |
Astex Pharmaceuticals, Inc. |
2012-05-31 |
| NCT01331525 |
The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01331525 |
Completed |
University Hospital Southampton NHS Foundation Trust |
2015-06-30 |
| NCT04400188 |
A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04400188 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2021-06-29 |
| NCT04381910 |
Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04381910 |
Recruiting |
Luye Pharma Group Ltd. |
2022-06-30 |
| NCT04361825 |
Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects |
https://ClinicalTrials.gov/show/NCT04361825 |
Enrolling by invitation |
Samsung Medical Center |
2023-05-31 |
| NCT04346914 |
Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04346914 |
Recruiting |
Lee’s Pharmaceutical Limited |
2020-12-31 |
| NCT04342429 |
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04342429 |
Recruiting |
Emory University |
2024-05-27 |
| NCT04332653 |
NT-I7 (Hyleukin-7) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04332653 |
Recruiting |
NeoImmuneTech |
2022-06-30 |
| NCT04256421 |
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04256421 |
Recruiting |
Hoffmann-La Roche |
2023-09-29 |
| NCT04254471 |
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients |
https://ClinicalTrials.gov/show/NCT04254471 |
Recruiting |
ShangHai HaiHe Pharmaceutical |
2022-05-22 |
| NCT04253145 |
Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. |
https://ClinicalTrials.gov/show/NCT04253145 |
Recruiting |
Fundacion Oncosur |
2020-12-31 |
| NCT04234113 |
Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT04234113 |
Recruiting |
Sotio a.s. |
2022-03-31 |
| NCT04229381 |
Resiliency Among Older Adults Receiving Lung Cancer Treatment |
https://ClinicalTrials.gov/show/NCT04229381 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2021-12-31 |
| NCT04209595 |
PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers |
https://ClinicalTrials.gov/show/NCT04209595 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT04192682 |
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04192682 |
Recruiting |
Changzhou Cancer Hospital of Soochow University |
2021-03-01 |
| NCT04187872 |
LITT and Pembrolizumab in Recurrent Brain Metastasis |
https://ClinicalTrials.gov/show/NCT04187872 |
Recruiting |
University of Florida |
2022-01-31 |
| NCT04180176 |
Prospective Clinicogenomic Program |
https://ClinicalTrials.gov/show/NCT04180176 |
Recruiting |
Genentech, Inc. |
2025-03-01 |
| NCT04173325 |
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04173325 |
Recruiting |
Augusta University |
2021-11-30 |
| NCT04171986 |
Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis |
https://ClinicalTrials.gov/show/NCT04171986 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2021-10-31 |
| NCT04168281 |
Watchful Observation of Patients With LD-SCLC Instead of the PCI |
https://ClinicalTrials.gov/show/NCT04168281 |
Recruiting |
University of Warmia and Mazury in Olsztyn |
2023-12-31 |
| NCT04165330 |
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors |
https://ClinicalTrials.gov/show/NCT04165330 |
Recruiting |
Sarcoma Oncology Research Center, LLC |
2021-12-31 |
| NCT04158336 |
A Study of ZN-c3 in Participants With Solid Tumors |
https://ClinicalTrials.gov/show/NCT04158336 |
Recruiting |
K-Group Beta |
2023-05-31 |
| NCT04155034 |
Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04155034 |
Recruiting |
Southwest Oncology Group |
2025-11-15 |
| NCT04128800 |
Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04128800 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2020-12-31 |
| NCT04116320 |
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04116320 |
Recruiting |
University of Virginia |
2022-11-30 |
| NCT04063163 |
A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) |
https://ClinicalTrials.gov/show/NCT04063163 |
Recruiting |
Shanghai Henlius Biotech |
2021-09-17 |
| NCT04056949 |
Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy |
https://ClinicalTrials.gov/show/NCT04056949 |
Recruiting |
Peking Union Medical College |
2021-02-01 |
| NCT04055792 |
Sintilimab Combined With Anlotinib in Third Line or Beyond Among Advanced SCLC Patients |
https://ClinicalTrials.gov/show/NCT04055792 |
Recruiting |
Henan Cancer Hospital |
2021-03-01 |
| NCT04028050 |
A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04028050 |
Recruiting |
Hoffmann-La Roche |
2022-12-30 |
| NCT04022876 |
A Study of ALRN-6924 for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04022876 |
Recruiting |
Aileron Therapeutics |
2021-03-31 |
| NCT04012606 |
Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04012606 |
Recruiting |
Shanghai Junshi Bioscience Co., Ltd. |
2021-07-06 |
| NCT04010357 |
Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC |
https://ClinicalTrials.gov/show/NCT04010357 |
Recruiting |
Case Comprehensive Cancer Center |
2021-12-31 |
| NCT03995667 |
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03995667 |
Recruiting |
OHSU Knight Cancer Institute |
2021-06-20 |
| NCT03994744 |
Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC |
https://ClinicalTrials.gov/show/NCT03994744 |
Recruiting |
Hunan Cancer Hospital |
2021-08-01 |
| NCT03983759 |
Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03983759 |
Recruiting |
Henan Cancer Hospital |
2021-05-31 |
| NCT03958045 |
Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma |
https://ClinicalTrials.gov/show/NCT03958045 |
Recruiting |
University of Kentucky |
2023-07-31 |
| NCT03913455 |
Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03913455 |
Recruiting |
Hoosier Cancer Research Network |
2020-06-30 |
| NCT03910660 |
A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03910660 |
Recruiting |
BioXcel Therapeutics Inc |
2022-04-02 |
| NCT03898791 |
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03898791 |
Active, not recruiting |
Eli Lilly and Company |
2020-06-02 |
| NCT03896503 |
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs |
https://ClinicalTrials.gov/show/NCT03896503 |
Recruiting |
National Cancer Institute (NCI) |
2023-09-01 |
| NCT03879798 |
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03879798 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-03-31 |
| NCT03849469 |
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03849469 |
Recruiting |
Xencor, Inc. |
2026-09-30 |
| NCT03841136 |
Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer |
https://ClinicalTrials.gov/show/NCT03841136 |
Recruiting |
Fudan University |
2019-12-01 |
| NCT03841110 |
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03841110 |
Recruiting |
Fate Therapeutics |
2022-03-31 |
| NCT03830918 |
Niraparib and Temozolomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy |
https://ClinicalTrials.gov/show/NCT03830918 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2021-01-03 |
| NCT03811379 |
Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy |
https://ClinicalTrials.gov/show/NCT03811379 |
Recruiting |
Sun Yat-sen University |
2020-12-30 |
| NCT03776604 |
PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT03776604 |
Recruiting |
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. |
2019-12-31 |
| NCT03769935 |
Maintenance Therapy for Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03769935 |
Recruiting |
Qingdao Central Hospital |
2020-01-01 |
| NCT03761914 |
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03761914 |
Recruiting |
Sellas Life Sciences Group |
2020-12-31 |
| NCT03752398 |
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) |
https://ClinicalTrials.gov/show/NCT03752398 |
Recruiting |
Xencor, Inc. |
2024-09-30 |
| NCT03735095 |
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer |
https://ClinicalTrials.gov/show/NCT03735095 |
Recruiting |
Roswell Park Cancer Institute |
2020-10-01 |
| NCT03732846 |
Anlotinib in Treatment of Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03732846 |
Recruiting |
Beijing Cancer Hospital |
2020-05-01 |
| NCT03728361 |
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer |
https://ClinicalTrials.gov/show/NCT03728361 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2021-12-31 |
| NCT03703297 |
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy |
https://ClinicalTrials.gov/show/NCT03703297 |
Recruiting |
AstraZeneca |
2024-02-19 |
| NCT03700359 |
A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC |
https://ClinicalTrials.gov/show/NCT03700359 |
Recruiting |
The First Affiliated Hospital of Guangzhou Medical University |
2020-11-29 |
| NCT03672773 |
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03672773 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2020-11-01 |
| NCT03662074 |
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03662074 |
Recruiting |
Wake Forest University Health Sciences |
2020-09-10 |
| NCT03661567 |
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03661567 |
Recruiting |
Sun Yat-sen University |
2021-09-30 |
| NCT03659578 |
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03659578 |
Recruiting |
Sun Yat-sen University |
2020-09-30 |
| NCT03652077 |
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03652077 |
Recruiting |
Incyte Corporation |
2021-01-31 |
| NCT03639194 |
A Study of ABBV-011 Alone and in Combination With ABBV-181 in Subjects With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03639194 |
Recruiting |
AbbVie |
2023-09-26 |
| NCT03613753 |
Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03613753 |
Recruiting |
Guizhou Medical University |
2020-06-01 |
| NCT03613597 |
Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03613597 |
Recruiting |
Guizhou Medical University |
2021-01-01 |
| NCT03585998 |
Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03585998 |
Active, not recruiting |
Samsung Medical Center |
2021-06-19 |
| NCT03583086 |
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors |
https://ClinicalTrials.gov/show/NCT03583086 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2023-07-31 |
| NCT03582475 |
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate |
https://ClinicalTrials.gov/show/NCT03582475 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2020-09-01 |
| NCT03575793 |
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03575793 |
Recruiting |
Big Ten Cancer Research Consortium |
2021-09-30 |
| NCT03568097 |
Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03568097 |
Recruiting |
Hellenic Cooperative Oncology Group |
2020-11-30 |
| NCT03554473 |
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers |
https://ClinicalTrials.gov/show/NCT03554473 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-01-15 |
| NCT03547804 |
A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03547804 |
Recruiting |
First Hospital of Jilin University |
2020-08-01 |
| NCT03540420 |
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03540420 |
Recruiting |
Norwegian University of Science and Technology |
2023-12-31 |
| NCT03538028 |
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03538028 |
Recruiting |
Incyte Corporation |
2020-09-24 |
| NCT03532880 |
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03532880 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT03523234 |
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage |
https://ClinicalTrials.gov/show/NCT03523234 |
Recruiting |
Shanghai Pulmonary Hospital, Shanghai, China |
2023-07-31 |
| NCT03517488 |
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03517488 |
Recruiting |
Xencor, Inc. |
2020-12-31 |
| NCT03516084 |
A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03516084 |
Recruiting |
Zai Lab (Shanghai) Co., Ltd. |
2019-10-31 |
| NCT03514849 |
Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03514849 |
Recruiting |
Shanghai Pulmonary Hospital, Shanghai, China |
2021-03-31 |
| NCT03509012 |
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03509012 |
Active, not recruiting |
AstraZeneca |
2022-04-04 |
| NCT03488472 |
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain |
https://ClinicalTrials.gov/show/NCT03488472 |
Recruiting |
University of Alabama at Birmingham |
2022-04-30 |
| NCT03467360 |
Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03467360 |
Recruiting |
Centre Antoine Lacassagne |
2021-11-30 |
| NCT03449901 |
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing’s Sarcoma, and Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03449901 |
Recruiting |
Washington University School of Medicine |
2021-05-09 |
| NCT03428607 |
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] |
https://ClinicalTrials.gov/show/NCT03428607 |
Active, not recruiting |
Samsung Medical Center |
2020-06-30 |
| NCT01266447 |
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01266447 |
Completed |
National Cancer Institute (NCI) |
2016-01-31 |
| NCT01253369 |
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01253369 |
Completed |
Dana-Farber Cancer Institute |
2012-09-30 |
| NCT01222936 |
LBH Phase II in Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT01222936 |
Completed |
Southern Europe New Drug Organization |
2009-06-30 |
| NCT01221675 |
TF2- Small Cell Lung Cancer Radio Immunotherapy |
https://ClinicalTrials.gov/show/NCT01221675 |
Completed |
Centre René Gauducheau |
2016-04-30 |
| NCT01173523 |
Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01173523 |
Completed |
Dana-Farber Cancer Institute |
2013-06-07 |
| NCT01166191 |
Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) |
https://ClinicalTrials.gov/show/NCT01166191 |
Completed |
Maastricht Radiation Oncology |
2017-05-31 |
| NCT01155258 |
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT01155258 |
Completed |
University of Southern California |
2013-01-31 |
| NCT01125995 |
Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01125995 |
Completed |
Samsung Medical Center |
2011-07-31 |
| NCT01079481 |
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01079481 |
Completed |
Samsung Medical Center |
2012-05-31 |
| NCT01076504 |
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01076504 |
Completed |
SCRI Development Innovations, LLC |
2012-03-31 |
| NCT01069653 |
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01069653 |
Completed |
Shiga University |
2019-03-31 |
| NCT01064466 |
Discovery Stage IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms |
https://ClinicalTrials.gov/show/NCT01064466 |
Active, not recruiting |
Medicine Invention Design, Inc |
2020-03-31 |
| NCT01057342 |
Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01057342 |
Completed |
Swiss Group for Clinical Cancer Research |
2011-05-31 |
| NCT01055197 |
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01055197 |
Completed |
Radiation Therapy Oncology Group |
2015-03-31 |
| NCT01045421 |
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies |
https://ClinicalTrials.gov/show/NCT01045421 |
Completed |
Millennium Pharmaceuticals, Inc. |
2013-05-31 |
| NCT01025284 |
A Study for Participants With Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT01025284 |
Completed |
Eli Lilly and Company |
2012-07-31 |
| NCT00984542 |
Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00984542 |
Completed |
Vanderbilt-Ingram Cancer Center |
2012-09-30 |
| NCT00951613 |
A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00951613 |
Completed |
Nippon Kayaku Co., Ltd. |
2012-01-31 |
| NCT00930891 |
Bevacizumab in Extensive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00930891 |
Completed |
Intergroupe Francophone de Cancerologie Thoracique |
2012-07-31 |
| NCT00927875 |
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00927875 |
Completed |
Bristol-Myers Squibb |
2012-09-30 |
| NCT00926640 |
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers |
https://ClinicalTrials.gov/show/NCT00926640 |
Completed |
National Institutes of Health Clinical Center (CC) |
2017-06-16 |
| NCT00921739 |
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies |
https://ClinicalTrials.gov/show/NCT00921739 |
Completed |
Duke University |
2014-12-31 |
| NCT00912392 |
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) |
https://ClinicalTrials.gov/show/NCT00912392 |
Completed |
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd |
2012-12-31 |
| NCT00907569 |
Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00907569 |
Completed |
AHS Cancer Control Alberta |
2011-04-30 |
| NCT00887159 |
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage |
https://ClinicalTrials.gov/show/NCT00887159 |
Completed |
National Cancer Institute (NCI) |
2016-11-15 |
| NCT00869752 |
MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00869752 |
Completed |
Canadian Cancer Trials Group |
2012-03-15 |
| NCT00856830 |
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00856830 |
Completed |
University of Alabama at Birmingham |
2015-05-31 |
| NCT00856037 |
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00856037 |
Completed |
University of Nebraska |
2018-02-01 |
| NCT04210037 |
Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04210037 |
Recruiting |
Ascentage Pharma Group Inc. |
2021-06-01 |
| NCT00828139 |
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00828139 |
Completed |
National Cancer Institute (NCI) |
2012-09-30 |
| NCT03850067 |
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03850067 |
Recruiting |
Celgene |
2021-09-30 |
| NCT03734913 |
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03734913 |
Recruiting |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2020-11-01 |
| NCT03253068 |
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03253068 |
Active, not recruiting |
Wakayama Medical University |
2020-12-28 |
| NCT01970540 |
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors |
https://ClinicalTrials.gov/show/NCT01970540 |
Completed |
PharmaMar |
2017-08-09 |
| NCT03708328 |
A Dose Escalation and Expansion Study of RO7121661, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT03708328 |
Recruiting |
Hoffmann-La Roche |
2023-05-31 |
| NCT03460977 |
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma |
https://ClinicalTrials.gov/show/NCT03460977 |
Recruiting |
Pfizer |
2023-03-31 |
| NCT02481830 |
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02481830 |
Active, not recruiting |
Bristol-Myers Squibb |
2018-08-17 |
| NCT04213937 |
Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04213937 |
Recruiting |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2021-07-31 |
| NCT04005716 |
Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT04005716 |
Recruiting |
BeiGene |
2021-07-31 |
| NCT03811652 |
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT03811652 |
Completed |
MedImmune LLC |
2019-12-10 |
| NCT03216343 |
Phase Ib Study of Chiauranib in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03216343 |
Recruiting |
Chipscreen Biosciences, Ltd. |
2020-08-30 |
| NCT02635009 |
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02635009 |
Recruiting |
NRG Oncology |
2022-04-30 |
| NCT04079712 |
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT04079712 |
Recruiting |
National Cancer Institute (NCI) |
2021-10-01 |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
https://ClinicalTrials.gov/show/NCT03866382 |
Recruiting |
National Cancer Institute (NCI) |
2023-02-28 |
| NCT02487095 |
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers |
https://ClinicalTrials.gov/show/NCT02487095 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-05-31 |
| NCT04453930 |
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC） |
https://ClinicalTrials.gov/show/NCT04453930 |
Recruiting |
Peking Union Medical College Hospital |
2023-06-30 |
| NCT03699956 |
RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT03699956 |
Active, not recruiting |
EpicentRx, Inc. |
2020-11-01 |
| NCT00791154 |
QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00791154 |
Completed |
NantCell, Inc. |
2012-06-30 |
| NCT00773955 |
R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00773955 |
Completed |
National Cancer Institute (NCI) |
2009-10-31 |
| NCT00759824 |
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide |
https://ClinicalTrials.gov/show/NCT00759824 |
Completed |
European Lung Cancer Working Party |
2013-12-31 |
| NCT00756639 |
Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium |
https://ClinicalTrials.gov/show/NCT00756639 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT00754858 |
Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00754858 |
Completed |
Yonsei University |
2010-05-31 |
| NCT00744900 |
Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC) |
https://ClinicalTrials.gov/show/NCT00744900 |
Completed |
University Hospital, Brest |
NA |
| NCT00740636 |
Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00740636 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-02-28 |
| NCT00717938 |
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00717938 |
Completed |
Lund University Hospital |
2017-05-31 |
| NCT00698516 |
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00698516 |
Completed |
GlaxoSmithKline |
2010-05-31 |
| NCT00695292 |
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00695292 |
Completed |
SCRI Development Innovations, LLC |
2011-06-30 |
| NCT00682981 |
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
https://ClinicalTrials.gov/show/NCT00682981 |
Completed |
Teva Pharmaceutical Industries |
2011-11-30 |
| NCT00658580 |
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00658580 |
Completed |
European Lung Cancer Working Party |
2013-12-31 |
| NCT00643396 |
Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00643396 |
Completed |
AHS Cancer Control Alberta |
2012-01-31 |
| NCT00632853 |
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide |
https://ClinicalTrials.gov/show/NCT00632853 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2023-06-30 |
| NCT00620347 |
Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00620347 |
Completed |
National Cancer Center, Korea |
2012-02-29 |
| NCT00617409 |
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid |
https://ClinicalTrials.gov/show/NCT00617409 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2015-09-21 |
| NCT00616109 |
Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC |
https://ClinicalTrials.gov/show/NCT00616109 |
Completed |
University of Michigan Rogel Cancer Center |
2009-12-31 |
| NCT00613626 |
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00613626 |
Completed |
Hoosier Cancer Research Network |
2015-08-31 |
| NCT01286987 |
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT01286987 |
Completed |
Pfizer |
2015-03-31 |
| NCT00580320 |
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00580320 |
Completed |
Virginia Commonwealth University |
2009-10-31 |
| NCT00554463 |
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00554463 |
Completed |
Radiation Therapy Oncology Group |
2011-08-31 |
| NCT00547651 |
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy |
https://ClinicalTrials.gov/show/NCT00547651 |
Completed |
Celgene |
2011-05-01 |
| NCT00544596 |
R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00544596 |
Completed |
National Cancer Institute (NCI) |
2013-07-31 |
| NCT00531284 |
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma |
https://ClinicalTrials.gov/show/NCT00531284 |
Completed |
Amgen |
2014-10-31 |
| NCT00528645 |
AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00528645 |
Completed |
National Cancer Institute (NCI) |
2008-11-30 |
| NCT00527735 |
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT00527735 |
Completed |
Bristol-Myers Squibb |
2009-10-31 |
| NCT00521144 |
Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00521144 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00483509 |
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma |
https://ClinicalTrials.gov/show/NCT00483509 |
Completed |
MolMed S.p.A. |
2010-09-22 |
| NCT00470054 |
Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00470054 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00469898 |
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00469898 |
Completed |
Vanderbilt-Ingram Cancer Center |
2008-07-31 |
| NCT00469222 |
Hypofractionated Radiotherapy for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00469222 |
Completed |
AHS Cancer Control Alberta |
2011-04-30 |
| NCT00466466 |
Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients |
https://ClinicalTrials.gov/show/NCT00466466 |
Completed |
Novartis |
2010-11-30 |
| NCT00466232 |
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00466232 |
Completed |
HealthPartners Institute |
2009-12-31 |
| NCT00455052 |
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00455052 |
Completed |
Mersana Therapeutics |
2011-12-31 |
| NCT00453167 |
Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00453167 |
Completed |
National Cancer Center, Korea |
2009-12-31 |
| NCT00453154 |
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00453154 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00452634 |
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) |
https://ClinicalTrials.gov/show/NCT00452634 |
Completed |
National Cancer Center, Korea |
2009-11-30 |
| NCT00445198 |
A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT00445198 |
Completed |
AbbVie |
2010-12-31 |
| NCT00020202 |
FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00020202 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019006 |
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer |
https://ClinicalTrials.gov/show/NCT00019006 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00433563 |
Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00433563 |
Completed |
The Christie NHS Foundation Trust |
2016-02-29 |
| NCT00433498 |
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00433498 |
Completed |
University College, London |
2012-01-31 |
| NCT00423254 |
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. |
https://ClinicalTrials.gov/show/NCT00423254 |
Completed |
Mannkind Corporation |
2009-09-30 |
| NCT00416455 |
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer |
https://ClinicalTrials.gov/show/NCT00416455 |
Completed |
National Cancer Institute (NCI) |
2014-09-30 |
| NCT00415363 |
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00415363 |
Completed |
Eli Lilly and Company |
2011-01-31 |
| NCT00403403 |
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) |
https://ClinicalTrials.gov/show/NCT00403403 |
Completed |
Genentech, Inc. |
2009-02-28 |
| NCT00401609 |
G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients |
https://ClinicalTrials.gov/show/NCT00401609 |
Completed |
National Cancer Institute, Naples |
2007-12-31 |
| NCT00397293 |
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00397293 |
Completed |
Ascenta Therapeutics |
2008-12-31 |
| NCT00388960 |
Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00388960 |
Completed |
Celgene |
2010-04-01 |
| NCT00387699 |
Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00387699 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00387660 |
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00387660 |
Completed |
University of California, Davis |
2008-08-31 |
| NCT00375193 |
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy |
https://ClinicalTrials.gov/show/NCT00375193 |
Completed |
Celgene |
2008-05-01 |
| NCT00374140 |
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00374140 |
Completed |
University of Pittsburgh |
2008-12-31 |
| NCT00363415 |
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00363415 |
Completed |
Eli Lilly and Company |
2008-06-30 |
| NCT00359359 |
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00359359 |
Completed |
Bayer |
2009-03-31 |
| NCT00349492 |
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer |
https://ClinicalTrials.gov/show/NCT00349492 |
Completed |
Clinical Research Center for Solid Tumor, Korea |
2011-12-31 |
| NCT00320359 |
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00320359 |
Completed |
GlaxoSmithKline |
2007-02-28 |
| NCT00319969 |
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. |
https://ClinicalTrials.gov/show/NCT00319969 |
Completed |
Celgene |
2008-07-31 |
| NCT00317200 |
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00317200 |
Completed |
Hoosier Cancer Research Network |
2007-11-30 |
| NCT00316186 |
First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin |
https://ClinicalTrials.gov/show/NCT00316186 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00309959 |
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer |
https://ClinicalTrials.gov/show/NCT00309959 |
Completed |
Gynecologic Oncology Group |
2011-02-28 |
| NCT00308529 |
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00308529 |
Completed |
SCRI Development Innovations, LLC |
2007-04-30 |
| NCT00305942 |
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00305942 |
Completed |
SCRI Development Innovations, LLC |
2009-04-30 |
| NCT00298896 |
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00298896 |
Completed |
Sunesis Pharmaceuticals |
2007-08-31 |
| NCT00298688 |
A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00298688 |
Completed |
AstraZeneca |
NA |
| NCT00294931 |
Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00294931 |
Completed |
SCRI Development Innovations, LLC |
2007-05-31 |
| NCT00294190 |
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00294190 |
Completed |
SCRI Development Innovations, LLC |
2007-09-30 |
| NCT00290953 |
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide |
https://ClinicalTrials.gov/show/NCT00290953 |
Completed |
Sanofi |
2006-03-31 |
| NCT00284154 |
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00284154 |
Completed |
SCRI Development Innovations, LLC |
2009-05-31 |
| NCT00282022 |
VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00282022 |
Completed |
National Cancer Institute (NCI) |
2008-05-31 |
| NCT00276276 |
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00276276 |
Completed |
GlaxoSmithKline |
NA |
| NCT00270166 |
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00270166 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00259935 |
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00259935 |
Completed |
GlaxoSmithKline |
2007-07-05 |
| NCT00252889 |
Doxil Topotecan Doublet Cancer Study |
https://ClinicalTrials.gov/show/NCT00252889 |
Completed |
Christiana Care Health Services |
2006-03-31 |
| NCT00248482 |
Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00248482 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2005-04-30 |
| NCT00245063 |
AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00245063 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00227565 |
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00227565 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-12-31 |
| NCT00217633 |
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer |
https://ClinicalTrials.gov/show/NCT00217633 |
Completed |
Gynecologic Oncology Group |
2013-01-31 |
| NCT00213798 |
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients |
https://ClinicalTrials.gov/show/NCT00213798 |
Completed |
University Hospital, Strasbourg, France |
NA |
| NCT00193401 |
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00193401 |
Completed |
SCRI Development Innovations, LLC |
2004-06-30 |
| NCT00193388 |
Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00193388 |
Completed |
SCRI Development Innovations, LLC |
2004-12-31 |
| NCT00193375 |
Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00193375 |
Completed |
SCRI Development Innovations, LLC |
2008-04-30 |
| NCT00191750 |
A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned |
https://ClinicalTrials.gov/show/NCT00191750 |
Completed |
Eli Lilly and Company |
NA |
| NCT00182689 |
Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00182689 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00156286 |
Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC |
https://ClinicalTrials.gov/show/NCT00156286 |
Completed |
University of Michigan Rogel Cancer Center |
2006-01-31 |
| NCT00144989 |
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC |
https://ClinicalTrials.gov/show/NCT00144989 |
Completed |
Japan Clinical Oncology Group |
2011-09-30 |
| NCT00143455 |
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00143455 |
Completed |
Pfizer |
2008-12-31 |
| NCT00132054 |
Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00132054 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00126828 |
Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00126828 |
Completed |
AHS Cancer Control Alberta |
2007-09-30 |
| NCT00119613 |
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa |
https://ClinicalTrials.gov/show/NCT00119613 |
Completed |
Amgen |
2007-01-31 |
| NCT00118235 |
Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00118235 |
Completed |
National Cancer Institute (NCI) |
2007-04-30 |
| NCT00116610 |
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00116610 |
Completed |
Poniard Pharmaceuticals |
2007-03-31 |
| NCT00104910 |
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer |
https://ClinicalTrials.gov/show/NCT00104910 |
Completed |
Gynecologic Oncology Group |
2013-01-31 |
| NCT00104793 |
Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00104793 |
Completed |
National Cancer Institute (NCI) |
2007-02-28 |
| NCT00098956 |
7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00098956 |
Completed |
National Cancer Institute (NCI) |
2010-06-30 |
| NCT00003279 |
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003279 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-01-31 |
| NCT00004186 |
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00004186 |
Completed |
University of Alabama at Birmingham |
2004-12-31 |
| NCT00003812 |
Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003812 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-06-30 |
| NCT00086827 |
Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00086827 |
Completed |
National Cancer Institute (NCI) |
2006-11-30 |
| NCT00005041 |
R115777 in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00005041 |
Completed |
NYU Langone Health |
2000-05-31 |
| NCT00084799 |
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00084799 |
Completed |
Ludwig Institute for Cancer Research |
NA |
| NCT00005032 |
Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00005032 |
Completed |
University of Chicago |
2001-01-31 |
| NCT00004055 |
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00004055 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-07-31 |
| NCT00004176 |
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00004176 |
Completed |
Washington University School of Medicine |
2001-02-28 |
| NCT00083161 |
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00083161 |
Completed |
Gundersen Lutheran Health System |
2010-05-31 |
| NCT00004249 |
Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy |
https://ClinicalTrials.gov/show/NCT00004249 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-11-30 |
| NCT00003917 |
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003917 |
Completed |
Case Comprehensive Cancer Center |
2001-11-30 |
| NCT00004137 |
S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00004137 |
Completed |
Southwest Oncology Group |
2004-03-31 |
| NCT00006487 |
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00006487 |
Completed |
Southwest Oncology Group |
2004-07-31 |
| NCT00005972 |
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00005972 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-10-31 |
| NCT00080015 |
Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT00080015 |
Completed |
Ipsen |
2005-02-28 |
| NCT00079040 |
Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00079040 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00003299 |
Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003299 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-06-30 |
| NCT00003011 |
Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003011 |
Completed |
Canadian Cancer Trials Group |
2001-02-13 |
| NCT00005022 |
Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00005022 |
Completed |
Radiation Therapy Oncology Group |
2002-10-31 |
| NCT00003364 |
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003364 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005646 |
Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00005646 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-01-31 |
| NCT00008372 |
Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00008372 |
Completed |
City of Hope Medical Center |
2002-09-30 |
| NCT00072527 |
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00072527 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-06-30 |
| NCT00006012 |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00006012 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-05-31 |
| NCT00003281 |
Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00003281 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-03-31 |
| NCT00068549 |
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer |
https://ClinicalTrials.gov/show/NCT00068549 |
Completed |
Gynecologic Oncology Group |
2008-01-31 |
| NCT00068289 |
Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT00068289 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00066742 |
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00066742 |
Completed |
National Cancer Institute (NCI) |
2009-08-31 |
| NCT00066313 |
ZD6474 in Treating Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00066313 |
Completed |
Sanofi |
2006-12-31 |
| NCT00066222 |
Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00066222 |
Completed |
Radiation Therapy Oncology Group |
2012-05-31 |
| NCT00006352 |
Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00006352 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-10-31 |
| NCT00065429 |
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00065429 |
Completed |
ImmunoGen, Inc. |
2008-11-30 |
| NCT00028925 |
Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00028925 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-11-30 |
| NCT00062322 |
Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00062322 |
Completed |
Fox Chase Cancer Center |
NA |
| NCT00062010 |
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00062010 |
Completed |
Eastern Cooperative Oncology Group |
2011-05-31 |
| NCT00061919 |
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00061919 |
Completed |
University College, London |
2007-02-28 |
| NCT00006349 |
Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00006349 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-01-31 |
| NCT00006082 |
Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00006082 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-08-31 |
| NCT00059761 |
Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00059761 |
Completed |
Radiation Therapy Oncology Group |
2009-03-31 |
| NCT00002822 |
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00002822 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00057837 |
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00057837 |
Completed |
Eastern Cooperative Oncology Group |
2012-01-31 |
| NCT00057746 |
Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00057746 |
Completed |
Radiation Therapy Oncology Group |
2009-05-31 |
| NCT00053300 |
Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00053300 |
Completed |
Case Comprehensive Cancer Center |
2005-11-30 |
| NCT00052949 |
Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00052949 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00052494 |
Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00052494 |
Completed |
University Health Network, Toronto |
2009-02-28 |
| NCT00049218 |
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00049218 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2007-06-30 |
| NCT00045604 |
Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00045604 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00045162 |
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00045162 |
Completed |
Southwest Oncology Group |
2008-03-31 |
| NCT00042978 |
Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00042978 |
Completed |
National Cancer Institute (NCI) |
2005-05-31 |
| NCT00041054 |
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00041054 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-08-31 |
| NCT00041015 |
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00041015 |
Completed |
Case Comprehensive Cancer Center |
2002-11-30 |
| NCT00033696 |
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00033696 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-01-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030433 |
S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00030433 |
Completed |
Southwest Oncology Group |
2007-02-28 |
| NCT00028535 |
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00028535 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00028028 |
CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00028028 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00025272 |
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00025272 |
Completed |
Wake Forest University Health Sciences |
2005-01-18 |
| NCT00022711 |
Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00022711 |
Completed |
Fox Chase Cancer Center |
2004-01-31 |
| NCT00017251 |
Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00017251 |
Completed |
National Cancer Institute (NCI) |
2004-01-31 |
| NCT00016211 |
Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00016211 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-03-31 |
| NCT00009971 |
Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00009971 |
Completed |
National Cancer Institute (NCI) |
2005-09-30 |
| NCT00005062 |
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission |
https://ClinicalTrials.gov/show/NCT00005062 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
2005-12-31 |
| NCT00046111 |
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00046111 |
Completed |
GlaxoSmithKline |
2004-04-30 |
| NCT00043927 |
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults |
https://ClinicalTrials.gov/show/NCT00043927 |
Completed |
GlaxoSmithKline |
2004-01-31 |
| NCT00043862 |
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) |
https://ClinicalTrials.gov/show/NCT00043862 |
Completed |
GlaxoSmithKline |
2005-11-30 |
| NCT00037817 |
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies |
https://ClinicalTrials.gov/show/NCT00037817 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-10-08 |
| NCT00037713 |
Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG |
https://ClinicalTrials.gov/show/NCT00037713 |
Completed |
Eli Lilly and Company |
2002-10-31 |
| NCT00046787 |
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00046787 |
Completed |
Astellas Pharma Inc |
NA |